Garmisch-Partenkirchen
Garmisch-Partenkirchen
Garmisch-Partenkirchen, Germany6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 14022 ATTUNE Cementless RP Clinical Performance Evaluation | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, rheumatic disorder | Active, not recruiting | Not applicable | 2026-09-28 | NCT02839850 | |
| Saracatinib Trial TO Prevent FOP | fibrodysplasia ossificans progressiva, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans | Active, not recruiting | Phase 2 | 2026-09-02 | NCT04307953 | |
| A Non-interventional, Prospective Study With Benralizumab | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Recruiting | Not stated | 2026-08-28 | NCT06422078 | |
| A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Active, not recruiting | Not stated | 2025-07-16 | NCT01848561 | |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 4 | 2025-05-16 | NCT05362760 | |
| Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project | B-cell chronic lymphocytic leukemia, Blood Protein Disorders, Hemic and Lymphatic Diseases, Infections, Leukemia, B-Cell, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2025-02-12 | NCT06821880 |